This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
(MedPage Today) -- Submaximal balloon angioplasty for symptomatic intracranial atherosclerotic stenosis (ICAS) improved outcomes over aggressive medical management alone, the BASIS trial from China showed. The incidence of the composite of any.
Traditional treatments like plain old balloon angioplasty (POBA) have limited success due to high restenosis rates. Drug-coated balloon angioplasty (DCBA) has emerged as a promising alternative, locally delivering antiproliferative drugs like paclitaxel to reduce restenosis. ResultsSixteen meta-analyses were included.
The goal of the IVUS-DCB trial was to evaluate intravascular ultrasound (IVUS)-guided drug-coated balloon angioplasty compared with angiography-guided drug-coated balloon angioplasty among patients with femoropopliteal artery disease.
This study aimed to analyze the safety and mid-term outcomes of a hybrid treatment method combining rotational atherectomy (RA) with drug-coated balloon (DCB) angioplasty in patients with femoropopliteal arter.
The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs. Half were randomly assigned to receive IVUS plus angiography and half received angiography alone.
A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine.
This review delves into the current therapeutic strategies for CTEPH, including surgical pulmonary endarterectomy (PEA), balloon pulmonary angioplasty (BPA), and targeted pharmacological treatments such as PDE5 inhibitors, endothelin receptor antagonists, sGC stimulators, and prostanoids.
Venita Chandra, director of vascular surgery, Stanford University School of Medicine, showed that DA followed by DCB achieved a significantly lower provisional stent rate with comparable safety and efficacy outcomes compared to standard predilatation prior to DCB, making it a viable alternative for treating long and highly calcified lesions.
Previous study data have shown improved procedural success with routine use of atherectomy in these patients without meaningful differences in clinical outcomes. Calcified coronary lesions are associated with lower procedural success and higher complications with percutaneous coronary intervention.
Santa Clara, CA, USA) semi compliant balloon adapted from cardiovascular literature which showed a pre‐dilation angioplasty capability in coronary stenotic lesions.MethodsWe performed a retrospective review of prospectively maintained mechanical thrombectomy (MT) databases of 2 comprehensive stroke centers between November 2020, and May 2023.
This causes angina, a type of chest pain which is characterized as refractory angina when this pain cannot be controlled by a combination of optimal medical therapy, angioplasty or bypass surgery, and is estimated to impact 600,000 to 1.8 million patients in the United States.
We included articles reporting patients > 18 years old with symptomatic extracranial vertebral artery stenoses due to atherosclerosis treated with stenting (with or without angioplasty). Patients’ characteristics, procedural details, complications, and outcomes were extracted.
Andreas Grüntzig was a German cardiologist best known for being the first to develop successful balloon angioplasty for expanding lumens of narrowed arteries. Improving patient care and outcomes is what drives my commitment to helping find new solutions in the field.
Publication date: Available online 10 December 2024 Source: The American Journal of Cardiology Author(s): Mauro Gitto, Pier Pasquale Leone, Francesco Gioia, Mauro Chiarito, Alessia Latini, Francesco Tartaglia, Ismail Dogu Kilic, Marco Luciano Rossi, Damiano Regazzoli, Gabriele Gasparini, Ottavia Cozzi, Alessandro Sticchi, Gianluigi Condorelli, Bernhard (..)
Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included. Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD).
Sacharias von Kochpresented " Real-World Usage of Prevail Paclitaxel-Coated Balloon Compared with Other Contemporary Drug-Coated Balloons" This is atwo-year analysis from the Swedish Coronary Angiography and Angioplasty (SCAAR) Registry in more than 6,000 patients. This study is a pooled analysis from the U.S.
Novel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the first randomized trial to compare clinical outcomes in previously untreated patients with non-complex disease undergoing percutaneous coronary intervention (PCI).
In cases of stent-retriever thrombectomy failure, rescue stent angioplasty might be the sole option for achieving permanent recanalization. We defined two binary outcomes: (1) functional clinical outcome (modified Rankin Scale 0-2) and (2) early symptomatic intracerebral hemorrhage (sICH). 10.43, p=0.0325).Conclusions:The
If a physician fails to cross a CTO, minimally invasive revascularization options such as angioplasty and stent placement cannot be performed. We are committed to advancing the field of interventional cardiology and improving patient outcomes through innovation." Hence, in the US, many CTO patients are instead sent for bypass surgery.
Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. Patients with poorly controlled diabetes also were more likely to require angioplasty (31.3% or greater. vs. 20.5%; p = 0.048) and stenting (28.4%
Publication date: Available online 7 January 2025 Source: The American Journal of Cardiology Author(s): Jooyeon Lee, Young-Guk Ko, Seung-Jun Lee, Chul-Min Ahn, Cheol Woong Yu, Jae-Hwan Lee, Seung-Whan Lee, Young Jin Youn, Jong Kwan Park, Chang-Hwan Yoon, Pil-Ki Min, Seung-Hyuk Choi, Donghoon Choi, K-VIS ELLA investigators
Improvements in outcomes following peripheral vascular intervention have lagged compared to other endovascular treatments, such as percutaneous coronary intervention. Ongoing collaboration among these specialties is paramount to improving outcomes for patients worldwide.” Tam, MD, MBA, FSIR.
Introduction:Current evidence suggests that acute carotid artery stenting (CAS) for cervical lesions is associated with better functional outcomes in patients with acute stroke with tandem lesions (TLs) treated with endovascular treatment (EVT). p=<0.001). p=<0.001).
We compared demographics, radiological findings, clinical outcomes, and follow-up results between mismatch and no mismatch groups.Results:Among 73 patients, 20 (27.4%) had DWI-ADC mismatch. Follow-up lesion volumes and functional outcomes were similar; however, the mismatch group showed a slower infarct growth rate (3.8 ml/h vs. 7.5
Our Interventional Cardiology Fellowship Program offers a unique opportunity for fellows to immerse themselves in high-volume centers and experience complex procedures such as angioplasties, stent placements, and Chronic Total Occlusion (CTO) interventions.
Initial suspicion of underlying ICAD could help in the early adoption of rescue techniques, reducing the total number of passes and increasing the chances of sustained final recanalization and favorable outcomes. There were no significant differences in baseline characteristics between IS+ and IS- patients.
1 Indeed, if the recently published ORBITA-2 trial demonstrated the benefit of revascularisation in relieving angina symptoms, 2 many other trials aiming to show a benefit on hard outcomes have failed in their purpose. 3 The ISCHEMIA-EXTEND reported the extended follow-up of the recent ISCHEMIA trial.
We assessed the clinical outcomes of endovascular treatment in acute large vessel occlusion (LVO) strokes caused by ICAD and compared them with large vessel occlusion strokes not associated with intracranial atherosclerosis (non-ICAD LVO).Methods:Our Stroke, Volume 55, Issue Suppl_1 , Page AWMP9-AWMP9, February 1, 2024. vs. 4%, p = 0.008).
Endovascular intervention was defined as either angioplasty, stenting, or a combination of both. Safety outcomes were comparable with similar rates of symptomatic intracranial hemorrhage (sICH).ConclusionWhile ResultsA total of 200 ICAD‐LVOS MT were identified. ResultsA total of 200 ICAD‐LVOS MT were identified.
The purpose of this study was to compare the outcomes of EVT for ICAD with those of cardiogenic cerebral embolism (CE) based on real-world data from a multicenter, prospective registry study (K-NET registry) involving 40 centers in Japan.Methods:The K-NET study enrolled 3187 EVTs in 2018-2021, of which 358 (11%) were ICAD and 1870 (59%) were CE.
Leveraging the reports, patient outcomes can be improved, and hospitals can provide improved patient care. The data collected through the registries can be utilized to study insights into patient characteristics, concurrent conditions, quality of care, patterns of care, underlying trends, comparative effectiveness, and clinical outcomes.
The primary outcomes were the incidence of limb occlusion and technical success during the follow-up period. Nonetheless, there were disparities in external iliac angioplasty between the two groups during the follow-up period (p < 0.05).ConclusionDeploying In contrast, group B consisted of those who did not receive a BMS.
Balloon angioplasty seems to be the widely preferred treatment of choice. Conclusion Our case demonstrates stenting as a viable alternative strategy with potentiallyfavorable long-term outcome. ABSTRACT Introduction Pulmonary vein (PV) restenosis develops with reported incidence rates of up to 50%.
With regard to vasospasm treatment, 80% had treatment with intra‐arterial verapamil and 40% underwent mechanical angioplasty. We did not perform balloon angioplasty in any case due to concern for rupture of the weakened compromised vessel walls.
National Inpatient Sample (NIS) database from 2009 to 2020, evaluating patients who presented with stroke from ICAD and were treated with angioplasty and stenting and analyzed presenting co-morbidities and patient outcomes. There were significantly higher incidences in uncontrolled hypertension (28.2% vs 7.9%), diabetes (33.6%
PVS intervention is frequently faced with in-stent restenosis and persistent disease progression despite initial venous recanalization with balloon angioplasty or stenting. Alterations in wall shear stress (WSS) have been previously associated with neointimal hyperplasia and venous stenosis underlying PVS progression.
There is increasing evidence to support the role of early intervention and treatment in affecting clinical outcomes in PH. Treatment escalation was defined as an additional pulmonary arterial hypertension (PAH) drug, pulmonary endarterectomy, percutaneous balloon angioplasty or bilateral lung transplantation.
Treatment of ICAS‐LVO with rescue stenting and/or angioplasty has shown promising outcomes, but diagnosing ICAS‐LVO during MT can be challenging [2, 3]. Most respondents (86%) preferred acute treatment of ICAS‐LVO with rescue stenting (RS) +/‐ angioplasty.
We aimed to evaluate the association between RS with functional outcomes compared to medical management (MM) in patients who underwent failed MT.Methods:This is a cross-sectional study using prospectively collected data from the Society of Vascular and Interventional Neurology (SVIN) Registry from 2018 to 2021.
Rescue strategies options, including balloon angioplasty alone, rescue stenting (RS) alone, or stent with balloon angioplasty, have shown promise in observational studies and meta‐analyses [3, 4]. The primary efficacy outcome was the shift in the degree of disability, as measured by the modified Rankin Scale (mRS), at 90 days.
This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.
Rescue treatment with stenting, balloon angioplasty, and/or intraarterial thrombolysis or antiplatelets are often required to treat the underlying stenosis. ConclusionPTAS appears to be an effective and safe treatment for ICAD after MT in the posterior circulation both improving likelihood of good outcomes and overall survival.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content